AXIM Biotechnologies, Inc.
Balance Sheet
| Line Item | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $156.5K | $47.3K | $453.0K | $457.2K | $511.6K | $1.8M | $2.1M | $713.3K |
| Accounts Receivable | — | — | — | — | $315.8K | $0 | — | — |
| Inventory | — | — | — | — | $487.8K | $9.8K | $8.8K | $38.4K |
| Total Current Assets | $156.5K | $104.0K | $636.6K | $713.1K | $1.6M | $2.0M | $2.1M | $1.4M |
| Property, Plant & Equipment | $134.1K | $93.8K | $116.8K | $104.1K | $2.2K | $5.6K | $8.9K | $12.3K |
| Goodwill | — | — | $0 | $2.5M | $0 | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | $50.5K | $53.7K | $63.2K | $63.2K |
| Total Assets | $4.1M | $4.2M | $5.3M | $11.3M | $1.7M | $2.1M | $2.2M | $1.4M |
| Liabilities | ||||||||
| Accounts Payable | $2.8M | $1.3M | — | $1.1M | $750.3K | $217.7K | $441.8K | $401.2K |
| Total Current Liabilities | $6.0M | $3.4M | $2.6M | $1.5M | $3.4M | $3.3M | $7.7M | $3.0M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $11.8M | $9.0M | $7.7M | $9.7M | $8.5M | $8.2M | $8.5M | $3.8M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-72.2M | $-64.1M | $-57.9M | $-41.8M | $-35.4M | $-29.0M | $-22.2M | $-18.1M |
| Total Stockholders' Equity | $-7.7M | $-4.8M | $-2.3M | $1.6M | $-6.8M | $-6.1M | $-6.3M | $-2.4M |